The undeniable success of 'Final Destination Bloodlines' means Death will get another go-round on the big screen.
From tech giants like Tesla to a little-known Bitcoin miner, the president's pro-crypto pivot has unleashed a tidal wave of wealth. Here’s who is riding it.
“I’m not talking about a little blue. I’m talking about neon blue, blueberry blue.”
The study calls into question whether a smartwatch can tell you much about your psychological state.
We asked IBM Quantum’s director about the reality of the current state of quantum computing.
Read 'It Might Be He Returns' by Fatima Taqvi on io9, courtesy of Lightspeed Magazine.
Released in 2000, the fourth 'Toxic Avenger' movie riffs on 'Citizen Kane,' 'The Wizard of Oz,' and 'Star Wars' in a gleeful puddle of bodily fluids and bad taste.
Seems overdue.
If Cregger gets his way, his desired DC film 'Henchman' could see a Gotham goon rise up after taking down the Batman... or did he?
The GPT-5 rollout has been a disaster.
The feat makes the microscopic world more tangible, while offering tantalizing opportunities for deeper investigations into complex quantum systems.
It might be the first documented case of AI-fueled poisoning.
Nothing squashes a comic book movie rumor quite like a tweet from the source saying 'nope.'
Chronic wounds in diabetes can take months to heal. In a diabetes mouse model, this new gel led to a 90% wound closure rate in just 12 days.
Anna Gomez says the new company is "born in shame."
After an early pitch for a new 'Enterprise' spinoff fizzled out, producer Michael Sussman believes Paramount's new ownership may be a chance to revive the idea.
The agency initially denied there was an issue.
Environmental groups allege that officials broke federal law by rushing construction without attaining public input or an environmental impact statement.
Intel’s chief executive says there is a lot of ‘misinformation’ circulating about his past.
What is this, a Nintendo Switch system for babies?
